tirzepatide for ckd GLP therapies have established themselves as kidney-protective in type 2 diabetes and high risk of kidney disease. This new post-hoc analysis of SURPASS-CVOT's kidney outcomes shows greater kidney protection with (#mounjaro) tirzepatide chronic kidney disease Obesity-Related
Description
Dose & Individual Tolerance Increasing or taking higher doses of Mounjaro can increase the medicines side effects of digestion
A $50 convenience fee will be added if you are within 30 miles of our office, and a $75 convenience fee will be added if you are outside 30 miles
Additionally, patients should feel confident in their injection technique and weekly administration routine
Specifically, the risk ratios for nausea ranged from 2.07 to 3.51 across different doses of tirzepatide, and from 2.45 to 2.84 for semaglutide (ESM Table 14)
Moura FA, Scirica BM, Ruff CT
